SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Accelerated Pharma, Inc. – ‘10-Q’ for 9/30/19 – ‘XML’

On:  Wednesday, 4/22/20, at 12:44pm ET   ·   For:  9/30/19   ·   Accession #:  1493152-20-6905   ·   File #:  333-227916

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/22/20  Accelerated Pharma, Inc.          10-Q        9/30/19   39:1.6M                                   M2 Compliance/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    191K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     15K 
23: R1          Document and Entity Information                     HTML     44K 
36: R2          Condensed Consolidated Balance Sheets               HTML     83K 
29: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML     54K 
                and Comprehensive Loss (Unaudited)                               
24: R5          Condensed Consolidated Statements of Changes in     HTML     60K 
                Stockholders' Deficiency (Unaudited)                             
37: R6          Condensed Consolidated Statements of Cash Flows     HTML     72K 
                (Unaudited)                                                      
30: R7          Business                                            HTML     21K 
14: R8          Going Concern and Management's Liquidity Plans      HTML     21K 
26: R9          Significant Accounting Policies                     HTML     36K 
19: R10         Out-of-Period Adjustment                            HTML     18K 
17: R11         Convertible Debt                                    HTML     21K 
27: R12         Notes Payable - Related Party                       HTML     16K 
38: R13         Stockholders' Equity                                HTML     18K 
20: R14         Subsequent Events                                   HTML     20K 
18: R15         Significant Accounting Policies (Policies)          HTML     58K 
28: R16         Significant Accounting Policies (Tables)            HTML     27K 
39: R17         Business (Details Narrative)                        HTML     15K 
22: R18         Going Concern and Management's Liquidity Plans      HTML     27K 
                (Details Narrative)                                              
16: R19         Significant Accounting Policies - Schedule of       HTML     18K 
                Foreign Currency Translation Exchange Rate                       
                (Details)                                                        
31: R20         Significant Accounting Policies - Schedule of       HTML     25K 
                Potentially Dilutive Securities Excluded from                    
                Computation of Net Loss Per Share (Details)                      
34: R21         Out-of-Period Adjustment (Details Narrative)        HTML     38K 
25: R22         Convertible Debt (Details Narrative)                HTML     39K 
13: R23         Notes Payable - Related Party (Details Narrative)   HTML     19K 
32: R24         Stockholders' Equity (Details Narrative)            HTML     28K 
35: R25         Subsequent Events (Details Narrative)               HTML     48K 
21: XML         IDEA XML File -- Filing Summary                      XML     61K 
33: EXCEL       IDEA Workbook of Financial Reports                  XLSX     32K 
 6: EX-101.INS  XBRL Instance -- accp-20190930                       XML    379K 
 8: EX-101.CAL  XBRL Calculations -- accp-20190930_cal               XML     79K 
 9: EX-101.DEF  XBRL Definitions -- accp-20190930_def                XML    241K 
10: EX-101.LAB  XBRL Labels -- accp-20190930_lab                     XML    352K 
11: EX-101.PRE  XBRL Presentations -- accp-20190930_pre              XML    319K 
 7: EX-101.SCH  XBRL Schema -- accp-20190930                         XSD     66K 
12: ZIP         XBRL Zipped Folder -- 0001493152-20-006905-xbrl      Zip     47K 


‘XML’   —   IDEA XML File — Filing Summary


This Document is an IDEA XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 83 </ContextCount>
<ElementCount> 195 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 28 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00000001 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00000002 - Statement - Condensed Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/BalanceSheets </Role>
<ShortName> Condensed Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/BalanceSheetsParenthetical </Role>
<ShortName> Condensed Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/StatementsOfOperationsAndComprehensiveLoss </Role>
<ShortName> Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficiency (unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/StatementsOfChangesInStockholdersDeficiency </Role>
<ShortName> Condensed Consolidated Statements of Changes in Stockholders' Deficiency (unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/StatementsOfCashFlows </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 00000007 - Disclosure - Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/Business </Role>
<ShortName> Business </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 00000008 - Disclosure - Going Concern and Management's Liquidity Plans </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/GoingConcernAndManagementsLiquidityPlans </Role>
<ShortName> Going Concern and Management's Liquidity Plans </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 00000009 - Disclosure - Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SignificantAccountingPolicies </Role>
<ShortName> Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 00000010 - Disclosure - Out-of-Period Adjustment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/Out-of-periodAdjustment </Role>
<ShortName> Out-of-Period Adjustment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 00000011 - Disclosure - Convertible Debt </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/ConvertibleDebt </Role>
<ShortName> Convertible Debt </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 00000012 - Disclosure - Notes Payable - Related Party </LongName>
<ReportType> Notes </ReportType>
<Role> http://apipharmaceuticals.com/role/NotesPayable-RelatedParty </Role>
<ShortName> Notes Payable - Related Party </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 00000013 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/StockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 00000014 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 00000015 - Disclosure - Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SignificantAccountingPoliciesPolicies </Role>
<ShortName> Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/SignificantAccountingPolicies </ParentRole>
<Position> 15 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 00000016 - Disclosure - Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SignificantAccountingPoliciesTables </Role>
<ShortName> Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/SignificantAccountingPolicies </ParentRole>
<Position> 16 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 00000017 - Disclosure - Business (Details Narrative) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/BusinessDetailsNarrative </Role>
<ShortName> Business (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/Business </ParentRole>
<Position> 17 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 00000018 - Disclosure - Going Concern and Management's Liquidity Plans (Details Narrative) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/GoingConcernAndManagementsLiquidityPlansDetailsNarrative </Role>
<ShortName> Going Concern and Management's Liquidity Plans (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/GoingConcernAndManagementsLiquidityPlans </ParentRole>
<Position> 18 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 00000019 - Disclosure - Significant Accounting Policies - Schedule of Foreign Currency Translation Exchange Rate (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SignificantAccountingPolicies-ScheduleOfForeignCurrencyTranslationExchangeRateDetails </Role>
<ShortName> Significant Accounting Policies - Schedule of Foreign Currency Translation Exchange Rate (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 00000020 - Disclosure - Significant Accounting Policies - Schedule of Potentially Dilutive Securities Excluded from Computation of Net Loss Per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfNetLossPerShareDetails </Role>
<ShortName> Significant Accounting Policies - Schedule of Potentially Dilutive Securities Excluded from Computation of Net Loss Per Share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 00000021 - Disclosure - Out-of-Period Adjustment (Details Narrative) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/Out-of-periodAdjustmentDetailsNarrative </Role>
<ShortName> Out-of-Period Adjustment (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/Out-of-periodAdjustment </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 00000022 - Disclosure - Convertible Debt (Details Narrative) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/ConvertibleDebtDetailsNarrative </Role>
<ShortName> Convertible Debt (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/ConvertibleDebt </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 00000023 - Disclosure - Notes Payable - Related Party (Details Narrative) </LongName>
<ReportType> Notes </ReportType>
<Role> http://apipharmaceuticals.com/role/NotesPayable-RelatedPartyDetailsNarrative </Role>
<ShortName> Notes Payable - Related Party (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/NotesPayable-RelatedParty </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 00000024 - Disclosure - Stockholders' Equity (Details Narrative) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/StockholdersEquityDetailsNarrative </Role>
<ShortName> Stockholders' Equity (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/StockholdersEquity </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="accp-20190930.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 00000025 - Disclosure - Subsequent Events (Details Narrative) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://apipharmaceuticals.com/role/SubsequentEventsDetailsNarrative </Role>
<ShortName> Subsequent Events (Details Narrative) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://apipharmaceuticals.com/role/SubsequentEvents </ParentRole>
<Position> 25 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> accp-20190930.xml </File>
<File> accp-20190930.xsd </File>
<File> accp-20190930_cal.xml </File>
<File> accp-20190930_def.xml </File>
<File> accp-20190930_lab.xml </File>
<File> accp-20190930_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/us-gaap/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

Top
Filing Submission 0001493152-20-006905   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 12:19:15.1am ET